Leaflet EMETOSTOP 30mg tablets

Product code:
W13788001
Quantity:
10
Indicated for:
nausea, vomiting and motion sickness
Route of administration:
oral
Substance:
meclozine (antiemetic)
ATC
R06AE05 — Respiratory system | Antihistamines for systemic use | Antihistamines for systemic use | Piperazine derivatives
Meclozine is a medication used to prevent and treat nausea, vomiting, and dizziness associated with motion sickness, vertigo, or other inner ear disorders such as Ménière's disease. It belongs to the class of H1 antihistamines and works by blocking histamine receptors in the brain, thereby reducing the sensation of nausea and dizziness.

Meclozine is available in tablet form and can be taken 1-2 hours before travel to prevent motion sickness. It is also sometimes used to treat nausea during pregnancy, but only under medical supervision.

Side effects may include drowsiness, dry mouth, fatigue, blurred vision, or, in rare cases, allergic reactions. Patients should avoid alcohol consumption or operating vehicles during treatment, as meclizine may impair alertness.
EMETOSTOP 30mg tablets SPECIFAR, meclozine

General data about EMETOSTOP 30mg

Substance:
meclozine
Date of latest medicines list:
01-05-2024
Product code:
W13788001
Concentration:
30mg
Pharmaceutical form:
tablets
Quantity:
10
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
SPECIFAR S.A. - GRECIA
Holder:
SPECIFAR S.A. - GRECIA
Number:
7611/2015/01
Shelf life:
3 years